Gurnet Point Capital

Gurnet Point Capital is a healthcare investment firm based in Cambridge, MA, focused on investing in scientifically de-risked life sciences companies. Founded in 2015, the firm employs an active ownership strategy to drive value creation through its financial capabilities, technical knowledge, and operational improvements. Gurnet Point Capital aims to bring safe and effective treatments to market, positively impacting patient outcomes and generating significant returns for investors. The fund invests across all stages of product development through to commercialisation and does so with an approach that is a hybrid of venture and private equity investing strategies.